NATCO PHARMA LTD. - 524816 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results along with Scrutinizers Report for the 39th Annual General Meeting held on 30th September, 202230-09-2022
30-09-2022
NATCO PHARMA LTD. - 524816 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 39th Annual General Meeting held on 30th September 202230-09-2022
NATCO PHARMA LTD. - 524816 - Closure of Trading Window
Closure of Trading Window for the quarter and half year ending 30th September, 202229-09-2022
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO Launches Chlorantraniliprole (CTPR) Product NATGEN24-09-2022
Natco Pharma: What helped the rally on Tuesday?
The companyNatco's patent challenge play pays-off in crop protection20-09-2022
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO gets CTPR launch approval from Delhi High Court19-09-2022
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding Issue of duplicate share Certificates16-09-2022
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News paper publication of 39th Annual General Meeting Notice03-09-2022
NATCO PHARMA LTD. - 524816 - Notice Of 39Th Annual General Meeting Of The Company
Notice of 39th Annual General meeting of the Company will be held on Friday, 30th September, 2022 at 10:30 A.M. (IST) through Video Conference / other Audio Visual Means02-09-2022
NATCO PHARMA LTD. - 524816 - Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2021-2202-09-2022